It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Autophagy is a catabolic process through which cytoplasmic components are degraded and recycled in response to various stresses including starvation. Recently, transcriptional and epigenetic regulations of autophagy have emerged as essential mechanisms for maintaining homeostasis. Here, we identify that coactivator-associated arginine methyltransferase 1 (CARM1) methylates Pontin chromatin-remodeling factor under glucose starvation, and methylated Pontin binds Forkhead Box O 3a (FOXO3a). Genome-wide analyses and biochemical studies reveal that methylated Pontin functions as a platform for recruiting Tip60 histone acetyltransferase with increased H4 acetylation and subsequent activation of autophagy genes regulated by FOXO3a. Surprisingly, CARM1-Pontin-FOXO3a signaling axis can work in the distal regions and activate autophagy genes through enhancer activation. Together, our findings provide a signaling axis of CARM1-Pontin-FOXO3a and further expand the role of CARM1 in nuclear regulation of autophagy.
Epigenetic regulations of autophagy have emerged as mechanisms for maintaining cellular homeostasis. Here the authors reveal that the CARM1-Pontin-FOXO3a signaling axis can activate autophagy related genes through enhancer activation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Kim, Dongha 3
; Baek, Seon Ah 1
; Choi, Seon Ah 1 ; Ahn Hyejin 1
; Amen, Shamim 4 ; Kim, Jeonghwan 5 ; Kim, Ik Soo 1
; Kim, Kyeong Kyu 4
; Kyoung-Jae, Won 5 ; Baek, Sung Hee 1 1 Seoul National University, Creative Research Initiatives Center for Epigenetic Code and Diseases, Department of Biological Sciences, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
2 Seoul National University, Creative Research Initiatives Center for Epigenetic Code and Diseases, Department of Biological Sciences, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); University of California Berkeley, Department of Molecular and Cell Biology, Berkeley, USA (GRID:grid.47840.3f) (ISNI:0000 0001 2181 7878)
3 The Catholic University of Korea, Department of Anatomy, College of Medicine, Seoul, South Korea (GRID:grid.411947.e) (ISNI:0000 0004 0470 4224)
4 Sungkyunkwan University, Department of Molecular Cell Biology, School of Medicine, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X)
5 University of Copenhagen, Biotech Research and Innovation Centre (BRIC), Copenhagen N, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); University of Copenhagen, Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, Copenhagen N, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)




